8C3E
Engineered mini-protein LCB2 (blocking ligand of SARS-Cov-2 spike protein)
Summary for 8C3E
Entry DOI | 10.2210/pdb8c3e/pdb |
Descriptor | Engineered protein LCB2, GLYCEROL (3 entities in total) |
Functional Keywords | sars-cov-2, mini-protein, antiviral, blocking ligand, antiviral protein |
Biological source | synthetic construct |
Total number of polymer chains | 1 |
Total formula weight | 7205.14 |
Authors | Korban, S.A.,Mikhailovskii, O.V.,Luzik, D.A.,Gurzhiy, V.V.,Levkina, A.D.,Kharkov, B.B.,Skrynnikov, N.R. (deposition date: 2022-12-23, release date: 2023-04-12, Last modification date: 2024-06-19) |
Primary citation | Korban, S.A.,Mikhailovskii, O.V.,Luzik, D.A.,Gurzhiy, V.V.,Levkina, A.D.,Kharkov, B.B.,Skrynnikov, N.R. Engineered mini-protein LCB2 (blocking ligand of SARS-Cov-2 spike protein) To Be Published, |
Experimental method | X-RAY DIFFRACTION (2.1 Å) |
Structure validation
Download full validation report